NCT07348926

Brief Summary

This study aims to examine the psychological status and quality of life of families with children who have rare genetic disorders. The focus of the study is to understand how the child's level of functional independence relates to the well-being of the family. Functional independence will be assessed using standardized tools, and parental psychological status and quality of life will be evaluated with validated questionnaires. The information gathered from this study may help improve the understanding of how rare genetic disorders affect family dynamics and daily functioning. The results may guide health care professionals in planning family-centered physiotherapy, psychological support, and care programs.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Oct 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 25, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 11, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 16, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2026

Completed
18 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2026

Completed
Last Updated

January 16, 2026

Status Verified

January 1, 2026

Enrollment Period

4 months

First QC Date

December 11, 2025

Last Update Submit

January 10, 2026

Conditions

Keywords

Rare Genetic Disordersphysical therapyDepressionQuality of LifeFamily

Outcome Measures

Primary Outcomes (1)

  • Functional Independence Level of the Child (WeeFIM)

    The functional independence level of children with rare genetic disorders will be assessed using the Pediatric Functional Independence Measure (WeeFIM). This scale evaluates functional abilities in self-care, mobility, and cognition. Higher scores indicate greater functional independence.

    At baseline (study enrollment)

Secondary Outcomes (5)

  • Beck Depression Inventory (BDI)

    At baseline (study enrollment)

  • Family Functionality in Rehabilitation

    At baseline (study enrollment)

  • Family Impact (Family Impact Scale)

    At baseline (study enrollment)

  • Sleep Quality (Pittsburgh Sleep Quality Index - PSQI)

    At baseline (study enrollment)

  • Quality of Life (Nottingham Health Profile - NHP)

    At baseline (study enrollment)

Study Arms (2)

Lower Functional Independence

Children with rare genetic disorders whose functional independence level is lower based on the Pediatric Functional Independence Measure (WeeFIM). Caregivers of these children are included in the study.

Higher Functional Independence

Children with rare genetic disorders whose functional independence level is higher based on the Pediatric Functional Independence Measure (WeeFIM). Caregivers of these children are included in the study.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of caregivers of children aged 0-4 years who have been diagnosed with rare genetic disorders and receive physiotherapy services at a rehabilitation center in Istanbul, Turkey. Participants are primary caregivers responsible for the child's daily care and able to complete Turkish-language questionnaires. The population reflects a clinical sample receiving ongoing rehabilitation, rather than a community-based or general population sample

You may qualify if:

  • Caregivers of children aged 0-4 years diagnosed with a rare genetic disorder.
  • The child must have been receiving physiotherapy for at least 6 months.
  • Caregivers who voluntarily agree to participate and provide informed consent.
  • Caregivers who are able to read and understand Turkish to complete the questionnaires.

You may not qualify if:

  • Caregivers who have cognitive or language limitations that prevent them from completing the questionnaires.
  • Caregivers who decline participation or submit incomplete questionnaire forms.
  • Children or caregivers with an additional medical or neurological condition that prevents participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bahcesehir University

Istanbul, 34053, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Tuğçe Tahmaz, PhD

    Bahçeşehir University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yağmur Erkan, PT

CONTACT

Tuğçe Tahmaz, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Graduate Student Researcher

Study Record Dates

First Submitted

December 11, 2025

First Posted

January 16, 2026

Study Start

October 25, 2025

Primary Completion

February 25, 2026

Study Completion

March 15, 2026

Last Updated

January 16, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations